Dan Jacob Gelvan

Dan Jacob Gelvan

Directeur Général chez
T-Syte Ltd.
61 ans
Health Technology
Consumer Services
Process Industries

Profil

Dan Jacob Gelvan is the founder of Zetiq Technologies Ltd. and Vecta Ltd. He currently holds the position of Chief Executive Officer at T-Syte Ltd. and Chief Executive Officer at Agplenus.
In the past, he has worked as the Chief Executive Officer of Gammacan International, Inc., Chairman & Chief Executive Officer of I2O Pharma Ltd., Chairman of Beta-O2 Technologies Ltd., Director of IntelliDx, Inc., Managing Director of Aurum Ventures MKI Ltd., Director of LifeBond Ltd., Director of CorAssist Cardiovascular Ltd., Independent Non-Executive Director of Vascular Biogenics Ltd., Director of Nephera Ltd., Director of FertiSeeds Ltd., and Principal of CLAL Israel Ltd. Dr. Gelvan has an undergraduate and graduate degree from The Hebrew University of Jerusalem and a doctorate from Roskilde University.

Postes actifs de Dan Jacob Gelvan

SociétésPosteDébut
Directeur Général -
Directeur Général 19/02/2024

Anciens postes connus de Dan Jacob Gelvan

SociétésPosteFin
Directeur Général 06/06/2005
Directeur Général -
Président -
Corporate Officer/Principal -
Fondateur -
Voir l'expérience en détail de Dan Jacob Gelvan

Formation de Dan Jacob Gelvan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées17

Health Technology

Electronic Technology

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Process Industries

Health Technology

Health Technology

Process Industries

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Dan Jacob Gelvan